Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 5
Submit an article Journal homepage
1,091
Views
14
CrossRef citations to date
0
Altmetric
Author's View

Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1

Erika VacchelliGustave Roussy Cancer Campus, Villejuif, France;INSERM, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France
,
Yuting MaGustave Roussy Cancer Campus, Villejuif, France;INSERM, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France;Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China;Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
,
Elisa E. BaraccoGustave Roussy Cancer Campus, Villejuif, France;INSERM, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France
,
Laurence ZitvogelGustave Roussy Cancer Campus, Villejuif, France;Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France;INSERM, Villejuif, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT)507, Villejuif, France
&
Guido KroemerGustave Roussy Cancer Campus, Villejuif, France;INSERM, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie, Paris, France;Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, SwedenCorrespondence[email protected]
Article: e1118600 | Received 04 Nov 2015, Accepted 04 Nov 2015, Published online: 22 Apr 2016

References

  • Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 2012; 337:1678-1684; PMID:23019653; http://dx.doi.org/10.1126/science.1224922
  • Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 2013; 39:74-88; PMID:23890065; http://dx.doi.org/10.1016/j.immuni.2013.06.014
  • Stoll G, Enot D, Mlecnik B, Galon J, Zitvogel L, Kroemer G. Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy. Oncoimmunology 2014; 3:e27884; PMID:24790795; http://dx.doi.org/10.4161/onci.27884
  • Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology 2014; 3:e955691; PMID:25941621; http://dx.doi.org/10.4161/21624011.2014.955691
  • Sukkurwala AQ, Adjemian S, Senovilla L, Michaud M, Spaggiari S, Vacchelli E, Baracco EE, Galluzzi L, Zitvogel L, Kepp O et al. Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set. Oncoimmunology 2014; 3:e28473; PMID:25050214; http://dx.doi.org/10.4161/onci.28473
  • Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2014; 3:e27878; PMID:24800173; http://dx.doi.org/10.4161/onci.27878
  • Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K et al. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity 2013; 38:729-741; PMID:23562161; http://dx.doi.org/10.1016/j.immuni.2013.03.003
  • Kroemer G, Senovilla L, Galluzzi L, André F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nature Medicine 2015; 21(10):1128-38; PMID:26444637; http://dx.doi.org/10.1038/nm.3944
  • Michaud M, Xie X, Bravo-San Pedro JM, Zitvogel L, White E, Kroemer G. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology 2014; 3:e944047; PMID:25610726; http://dx.doi.org/10.4161/21624011.2014.944047
  • Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M et al. Chemotherapy-induced anti-tumor immunity requires formyl peptide receptor 1 Science 2015; PMID:26516201; http://dx.doi.org/10.1126/science.aad0779

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.